Braidwell LP

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Braidwell LP reported 58 stock positions worth $2.0 billion. Its top holding was Neurocrine Biosciences (NBIX) at 5.3% of the portfolio, followed by CG Oncology (CGON, 5.3%) and Xenon Pharmaceuticals (XENE, 5.1%). Compared with Q1 2024, it opened 17 new positions, sold out of 10, added to 26 and reduced 11. The biggest buy was CG Oncology (CGON, shares +193%) and the biggest sale Penumbra (PEN, shares −28%).

Most Recent 13F
Q2 2026
Location
STAMFORD, CT
CIK
0001920938
Portfolio Value
$2.0B (Q2 2024)
SEC Filing
0001420506-24-001566 ↗ filed Aug 14, 2024

Holdings Value

0$1.0B$2.0B$3.0B Q1 2024: $1.8B Q1 2024 Q2 2024: $2.0B $2.0B Q2 2024 Q3 2024: $2.3B Q3 2024 Q4 2024: $2.2B Q4 2024 Q1 2025: $1.9B Q1 2025 Q2 2025: $2.1B Q2 2025 Q3 2025: $2.5B Q3 2025 Q4 2025: $2.6B Q4 2025 Q1 2026: $2.6B Q1 2026 Q2 2026: $2.6B Q2 2026

Holdings 58 stocks · $2.0B
NBIX Neurocrine Biosciences Inc. 5.35% 759,009 $104.5M Add +3.9%
CGON CG Oncology Inc. 5.35% 3,309,507 $104.5M Add +192.8%
XENE Xenon Pharmaceuticals Inc. 5.11% 2,560,573 $99.8M Add +95.8%
APGE Apogee Therapeutics Inc. 4.82% 2,392,042 $94.1M Add +29.8%
GH Guardant Health Inc. 4.15% 2,807,968 $81.1M Add +13.4%
LEGN Legend Biotech Corp.-ADR 3.78% 1,669,720 $74.0M Add +34.2%
ARGX Argenx SE - ADR 3.67% 166,924 $71.8M Reduce -24.1%
ALGN Align Technology Inc. 3.40% 275,207 $66.4M Add +62.6%
MRVI Maravai Lifesciences Hldgs-A 3.31% 9,024,037 $64.6M Add +24.9%
PCVX Vaxcyte Inc. 3.12% 808,303 $61.0M Reduce -33.4%
SYRE Spyre Therapeutics Inc. 3.03% 2,514,538 $59.1M Add +388.3%
GKOS Glaukos Corp. 3.01% 496,576 $58.8M Add +10.2%
VKTX Viking Therapeutics Inc. 3.00% 1,106,905 $58.7M Add +55.2%
IRTC Irhythm Holdings Inc. 2.90% 526,357 $56.7M Add +8.9%
INSP Inspire Medical Systems Inc. 2.60% 379,443 $50.8M Add +273.9%
EXAS Exact Sciences Corp. 2.47% 1,141,678 $48.2M New
KROS Keros Therapeutics Inc. 2.30% 982,209 $44.9M Add +33.2%
ISRG Intuitive Surgical Inc. 2.29% 100,500 $44.7M No change
DAWN Day One Biopharmaceuticals I 2.14% 3,035,904 $41.8M Add +39.7%
RGEN Repligen Corp. 2.09% 323,509 $40.8M Add +126.5%
AVDL Avadel Pharmaceuticals Ltd. 2.09% 2,898,639 $40.8M Add +8.6%
TMO Thermo Fisher Scientific Inc. 1.99% 70,449 $39.0M Add +49.4%
KNSA Kiniksa Pharmaceuticals Inte 1.97% 2,058,303 $38.4M Add +47.8%
PEN Penumbra Inc. 1.96% 212,594 $38.3M Reduce -28.1%
KIDS Orthopediatrics Corp. 1.63% 1,107,770 $31.9M No change
IRWD Ironwood Pharmaceuticals Inc. 1.48% 4,438,232 $28.9M Add +27.2%
TMDX Transmedics Group Inc. 1.46% 189,960 $28.6M Reduce -69.1%
FNA Paragon 28 Inc. 1.45% 4,150,109 $28.4M Add +23.3%
IMCR Immunocore Holdings PLC-ADR 1.38% 797,268 $27.0M New
AKRO Akero Therapeutics Inc. 1.30% 1,084,400 $25.4M New
APLS Apellis Pharmaceuticals Inc. 1.20% 611,800 $23.5M New
ATEC Alphatec Holdings Inc. 1.17% 2,194,900 $22.9M New
LXEO Lexeo Therapeutics Inc. 1.13% 1,382,481 $22.2M Add +4.5%
KRYS Krystal Biotech Inc. 1.01% 107,179 $19.7M Reduce -39.5%
RLAY Relay Therapeutics Inc. 1.00% 3,006,799 $19.6M Reduce -19.7%
NVRO Nevro LLC filed as NEVRO CORP 0.73% 1,698,768 $14.3M Reduce -4.4%
LXRX Lexicon Pharmaceuticals Inc. 0.71% 8,294,950 $13.9M New
ARVN Arvinas Inc. 0.70% 517,230 $13.8M New
SRPT Sarepta Therapeutics Inc. 0.66% 81,900 $12.9M New
IOVA Iovance Biotherapeutics Inc. 0.60% 1,466,610 $11.8M Add +122.2%
OCUL Ocular Therapeutix Inc. 0.58% 1,643,770 $11.2M New
ALEC Alector Inc. 0.55% 2,380,704 $10.8M No change
SKIN Skinhealth Systems Inc. filed as THE BEAUTY HEALTH COMPANY 0.50% 5,120,685 $9.8M New
LIVN Livanova PLC 0.49% 173,900 $9.5M New
DNTH Dianthus Therapeutics Inc. 0.49% 366,851 $9.5M New
REPL Replimune Group Inc. 0.47% 1,013,377 $9.1M New
CSTL Castle Biosciences Inc. 0.46% 416,100 $9.1M New
BBIO Bridgebio Pharma Inc. 0.45% 345,571 $8.8M Add +0.2%
CELC Celcuity Inc. 0.43% 516,643 $8.5M New
FDMT 4D Molecular Therapeutics Inc. 0.40% 369,458 $7.8M Reduce -64.9%
ELEV Elevation Oncology Inc. 0.34% 2,477,614 $6.7M Add +4.2%
HROW Harrow Inc. 0.32% 297,188 $6.2M Add +135.9%
LBPH Longboard Pharmaceuticals Inc. 0.28% 205,926 $5.6M New
LUNG Pulmonx Corp. 0.24% 752,541 $4.8M No change
CGEM Cullinan Therapeutics Inc. 0.16% 176,173 $3.1M Reduce -85.8%
OM Outset Medical Inc. 0.14% 694,525 $2.7M Reduce -71.1%
DBV TECHNOLOGIES S A 0.10% 2,442,504 $2.0M Reduce -37.7%
ETNB 89BIO Inc. 0.07% 164,227 $1.3M New
Other holdings (17): bonds, preferreds, convertibles and warrants · $1.2B (not counted above)
SecurityClassShares / PrincipalValueChange
GUARDANT HEALTH INC (GH 0 11/15/27) NOTE 11/1 · principal 268,252,000$208.1MNo change
BRIDGEBIO PHARMA INC (BBIO 2.5 03/15/27) NOTE 2.500% 3/1 · principal 140,838,000$143.0MAdd +3.7%
NOVOCURE LTD (NVCR 0 11/01/25) NOTE 11/0 · principal 140,834,000$129.8MAdd +3.7%
NUVASIVE INC (GMED 0.375 03/15/25) NOTE 0.375% 3/1 · principal 114,206,000$110.1MNo change
NEOGENOMICS INC (NEO 0.25 01/15/28) NOTE 0.250% 1/1 · principal 116,381,000$90.8MAdd +12.4%
IRONWOOD PHARMACEUTICALS (IRWD 1.5 06/15/26) NOTE 1.500% 6/1 · principal 89,740,000$84.6MAdd +70.2%
DEXCOM INC (DXCM 0.375 05/15/28) NOTE 0.375% 5/1 · principal 82,700,000$81.2MNew
INSULET CORPORATION (PODD 0.375 09/01/26) NOTE 0.375% 9/0 · principal 68,000,000$74.4MAdd +3.0%
DEXCOM INC (DXCM 0.25 11/15/25) NOTE 0.250%11/1 · principal 73,500,000$73.8MAdd +13.1%
ALPHATEC HOLDINGS INC (ATEC 0.75 08/01/26) NOTE 0.750% 8/0 · principal 58,217,000$56.6MAdd +79.5%
SAREPTA THERAPEUTICS INC (SRPT 1.25 09/15/27) NOTE 1.250% 9/1 · principal 43,066,000$55.5MReduce -15.0%
BRIDGEBIO PHARMA INC (BBIO 2.25 02/01/29) NOTE 2.250% 2/0 · principal 65,594,000$52.3MReduce -2.5%
TRAVERE THERAPEUTICS INC (TVTX 2.5 09/15/25) NOTE 2.500% 9/1 · principal 56,031,000$48.8MNo change
HAEMONETICS CORP (HAE 0 03/01/26) NOTE 3/0 · principal 11,500,000$10.4MReduce -46.5%
CUTERA INC (CUTR 2.25 06/01/28) NOTE 2.250% 6/0 · principal 25,240,000$5.0MNo change
CUTERA INC (CUTR 4 06/01/29) NOTE 4.000% 6/0 · principal 29,000,000$5.0MNo change
CONMED CORP (CNMD 2.25 06/15/27) NOTE 2.250% 6/1 · principal 5,000,000$4.5MNew

Total filed on the 13F, all lines: $3.2B.

Portfolio Sells Q1 2024 → Q2 2024
PEN Penumbra Inc. Reduce -28.1% 1.96% −1.76
PCVX Vaxcyte Inc. Reduce -33.4% 3.12% −1.54
FDMT 4D Molecular Therapeutics Inc. Reduce -64.9% 0.40% −1.49
ARGX Argenx SE - ADR Reduce -24.1% 3.67% −1.20
TRML Tourmaline Bio Inc. Sold out 0.00% −1.17
TMDX Transmedics Group Inc. Reduce -69.1% 1.46% −1.10
BMRN Biomarin Pharmaceutical Inc. Sold out 0.00% −1.08
GPCR Structure Therapeutics Inc. Sold out 0.00% −1.05
CGEM Cullinan Therapeutics Inc. Reduce -85.8% 0.16% −1.03
BCRX Biocryst Pharmaceuticals Inc. Sold out 0.00% −0.97
ITOS Iteos Therapeutics Inc. Sold out 0.00% −0.89
MLYS Mineralys Therapeutics Inc. Sold out 0.00% −0.83
KRYS Krystal Biotech Inc. Reduce -39.5% 1.01% −0.77
RLAY Relay Therapeutics Inc. Reduce -19.7% 1.00% −0.75
ARQT Arcutis Biotherapeutics Inc. Sold out 0.00% −0.73
NVRO Nevro LLC Reduce -4.4% 0.73% −0.71
DCPH Deciphera Pharmaceuticals Inc. Sold out 0.00% −0.54
OLMA Olema Pharmaceuticals Inc. Sold out 0.00% −0.45
ADPT Adaptive Biotechnologies Sold out 0.00% −0.25
DBV TECHNOLOGIES S A Reduce -37.7% 0.10% −0.23
OM Outset Medical Inc. Reduce -71.1% 0.14% −0.16

Portfolio Buys Q1 2024 → Q2 2024
CGON CG Oncology Inc. Add +192.8% 5.35% +2.55
EXAS Exact Sciences Corp. New 2.47% +2.47
XENE Xenon Pharmaceuticals Inc. Add +95.8% 5.11% +1.94
SYRE Spyre Therapeutics Inc. Add +388.3% 3.03% +1.92
IMCR Immunocore Holdings PLC-ADR New 1.38% +1.38
INSP Inspire Medical Systems Inc. Add +273.9% 2.60% +1.37
AKRO Akero Therapeutics Inc. New 1.30% +1.30
GH Guardant Health Inc. Add +13.4% 4.15% +1.27
APLS Apellis Pharmaceuticals Inc. New 1.20% +1.20
ATEC Alphatec Holdings Inc. New 1.17% +1.17
LXRX Lexicon Pharmaceuticals Inc. New 0.71% +0.71
ARVN Arvinas Inc. New 0.70% +0.70
SRPT Sarepta Therapeutics Inc. New 0.66% +0.66
GKOS Glaukos Corp. Add +10.2% 3.01% +0.61
RGEN Repligen Corp. Add +126.5% 2.09% +0.61
OCUL Ocular Therapeutix Inc. New 0.58% +0.58
SKIN Skinhealth Systems Inc. New 0.50% +0.50
LIVN Livanova PLC New 0.49% +0.49
DNTH Dianthus Therapeutics Inc. New 0.49% +0.49
REPL Replimune Group Inc. New 0.47% +0.47
CSTL Castle Biosciences Inc. New 0.46% +0.46
TMO Thermo Fisher Scientific Inc. Add +49.4% 1.99% +0.45
CELC Celcuity Inc. New 0.43% +0.43
KNSA Kiniksa Pharmaceuticals Inte Add +47.8% 1.97% +0.42
LBPH Longboard Pharmaceuticals Inc. New 0.28% +0.28
ALGN Align Technology Inc. Add +62.6% 3.40% +0.27
HROW Harrow Inc. Add +135.9% 0.32% +0.22
DAWN Day One Biopharmaceuticals I Add +39.7% 2.14% +0.12
ETNB 89BIO Inc. New 0.07% +0.07
IOVA Iovance Biotherapeutics Inc. Add +122.2% 0.60% +0.05
LXEO Lexeo Therapeutics Inc. Add +4.5% 1.13% −0.03
LEGN Legend Biotech Corp.-ADR Add +34.2% 3.78% −0.15
BBIO Bridgebio Pharma Inc. Add +0.2% 0.45% −0.15
MRVI Maravai Lifesciences Hldgs-A Add +24.9% 3.31% −0.22
IRWD Ironwood Pharmaceuticals Inc. Add +27.2% 1.48% −0.23
IRTC Irhythm Holdings Inc. Add +8.9% 2.90% −0.26
VKTX Viking Therapeutics Inc. Add +55.2% 3.00% −0.29
NBIX Neurocrine Biosciences Inc. Add +3.9% 5.35% −0.33
ELEV Elevation Oncology Inc. Add +4.2% 0.34% −0.35
KROS Keros Therapeutics Inc. Add +33.2% 2.30% −0.45
AVDL Avadel Pharmaceuticals Ltd. Add +8.6% 2.09% −0.45
FNA Paragon 28 Inc. Add +23.3% 1.45% −0.89
APGE Apogee Therapeutics Inc. Add +29.8% 4.82% −2.08

Notes & Other Activity Q1 2024 → Q2 2024
BRIDGEBIO PHARMA INC (BBIO 2.5 03/15/27) NOTE 2.500% 3/1 · principal Add +3.7% 140,838,000 $143.0M
EXACT SCIENCES CORP (EXAS 0.375 03/01/28) NOTE 0.375% 3/0 · principal Sold out 144,000,000 $133.1Mbefore exit
NOVOCURE LTD (NVCR 0 11/01/25) NOTE 11/0 · principal Add +3.7% 140,834,000 $129.8M
NEOGENOMICS INC (NEO 0.25 01/15/28) NOTE 0.250% 1/1 · principal Add +12.4% 116,381,000 $90.8M
IRONWOOD PHARMACEUTICALS (IRWD 1.5 06/15/26) NOTE 1.500% 6/1 · principal Add +70.2% 89,740,000 $84.6M
DEXCOM INC (DXCM 0.375 05/15/28) NOTE 0.375% 5/1 · principal New 82,700,000 $81.2M
INSULET CORPORATION (PODD 0.375 09/01/26) NOTE 0.375% 9/0 · principal Add +3.0% 68,000,000 $74.4M
DEXCOM INC (DXCM 0.25 11/15/25) NOTE 0.250%11/1 · principal Add +13.1% 73,500,000 $73.8M
INSMED INC (INSM 1.75 01/15/25) NOTE 1.750% 1/1 · principal Sold out 64,887,000 $69.4Mbefore exit
ALPHATEC HOLDINGS INC (ATEC 0.75 08/01/26) NOTE 0.750% 8/0 · principal Add +79.5% 58,217,000 $56.6M
SAREPTA THERAPEUTICS INC (SRPT 1.25 09/15/27) NOTE 1.250% 9/1 · principal Reduce -15.0% 43,066,000 $55.5M
BRIDGEBIO PHARMA INC (BBIO 2.25 02/01/29) NOTE 2.250% 2/0 · principal Reduce -2.5% 65,594,000 $52.3M
KARYOPHARM THERAPEUTICS (KPTI 3 10/15/25) NOTE 3.000%10/1 · principal Sold out 65,976,000 $35.8Mbefore exit
IRONWOOD PHARMACEUTICALS (IRWD 0.75 06/15/24) NOTE 0.750% 6/1 · principal Sold out 20,000,000 $19.9Mbefore exit
HAEMONETICS CORP (HAE 0 03/01/26) NOTE 3/0 · principal Reduce -46.5% 11,500,000 $10.4M
CONMED CORP (CNMD 2.25 06/15/27) NOTE 2.250% 6/1 · principal New 5,000,000 $4.5M

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 83$2.6BCAI, HNGE, GKOS, EWTX, SYRE
Q1 2026 82$2.6BCAI, NBIX, GKOS, CNTA, XENE
Q4 2025 68$2.6BCAI, EWTX, NBIX, GKOS, NUVL
Q3 2025 64$2.5BCAI, XENE, CGON, NBIX, KRYS
Q2 2025 45$2.1BCAI, NBIX, XENE, ARGX, KRYS
Q1 2025 52$1.9BNBIX, LEGN, ARGX, XENE, ALGN
Q4 2024 59$2.2BNBIX, XENE, LEGN, CGON, GH
Q3 2024 65$2.3BCGON, XENE, NBIX, APGE, APLS
Q2 2024 58$2.0BNBIX, CGON, XENE, APGE, GH
Q1 2024 51$1.8BAPGE, NBIX, ARGX, PCVX, LEGN